Open access

Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e001701corr1; DOI: 10.1136/jitc-2020-001701corr1
⁶⁸Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
Sarah Boughdad, Sofiya Latifyan, Craig Fenwick, Hasna Bouchaab, Madeleine Suffiotti, Javid J Moslehi, Joe-Elie Salem, Niklaus Schaefer, Marie Nicod-Lalonde, Julien Costes, Matthieu Perreau, Olivier Michielin, Solange Peters, John O Prior, Michel Obeid

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003594; DOI: 10.1136/jitc-2021-003594
Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment
Wan-Lun Yan, Chiao-Chieh Wu, Kuan-Yin Shen, Shih-Jen Liu

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e002758; DOI: 10.1136/jitc-2021-002758
Correction: Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e002886corr1; DOI: 10.1136/jitc-2021-002886corr1
Correction: In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e001481corr1; DOI: 10.1136/jitc-2020-001481corr1
Correction: TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer
Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e002044corr1; DOI: 10.1136/jitc-2020-002044corr1
Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growth
Anne Marijne Heeren, Jossie Rotman, Sanne Samuels, Henry J M A A Zijlmans, Guus Fons, Koen K van de Vijver, Maaike C G Bleeker, Gemma G Kenter, Ekaterina J Jordanova, Tanja D de Gruijl

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003623; DOI: 10.1136/jitc-2021-003623
Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
Shih-Hsun Chen, Pawel K Dominik, Jessica Stanfield, Sheng Ding, Wenjing Yang, Nadia Kurd, Ryan Llewellyn, Jonathan Heyen, Carole Wang, Zea Melton, Thomas Van Blarcom, Kevin C Lindquist, Javier Chaparro-Riggers, Shahram Salek-Ardakani

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003464; DOI: 10.1136/jitc-2021-003464
Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy
Marie Tourret, Nana Talvard-Balland, Marion Lambert, Ghada Ben Youssef, Mathieu F Chevalier, Armelle Bohineust, Thomas Yvorra, Florence Morin, Saba Azarnoush, Olivier Lantz, Jean-Hugues Dalle, Sophie Caillat-Zucman

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003123; DOI: 10.1136/jitc-2021-003123
Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice
Cangang Zhang, Lei Lei, Xiaofeng Yang, Kaili Ma, Huiqiang Zheng, Yanhong Su, Anjun Jiao, Xin Wang, Haiyan Liu, Yujing Zou, Lin Shi, Xiaobo Zhou, Chenming Sun, Yuzhu Hou, Zhengtao Xiao, Lianjun Zhang, Baojun Zhang

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e002809; DOI: 10.1136/jitc-2021-002809

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages